This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lintern, M. Articles by Ferry, C. Search for Related Content PubMed PubMed Citation Articles by Lintern, M. Articles by Ferry, C. Social Bookmarking                   What's this?

Effect of repeated treatment with pyridostigmine on acetylcholinesterase in mouse muscles

Department of Physiology, The Medical School, University of Birmingham, Birmingham, B15 2TT

ME Smith

Department of Physiology, The Medical School, University of Birmingham, Birmingham, B15 2TT

CB Ferry

Department of Pharmaceutical and Biological Sciences, University of Aston, Birmingham, B4 7ET, UK

1 Pyridostigmine bromide was administered subcuta neously (0.4 µmoles/kg) in mice twice a day for 3 weeks. The activities of the predominant (G1, G4 and A12) molecular forms of acetylcholinesterase were determined in diaphragm, extensor digitorum longus (EDL) and soleus muscles.

2 After the treatment the G4 and A12 forms were reduced in diaphragm, but increased in EDL and soleus. One week later all forms were elevated in all three muscles. At 2 weeks the activity had returned to normal in diaphragm but not in EDL and soleus.

3 A single dose of pyridostigmine was administered in mice which had been pretreated for 3 weeks and left untreated for 2 weeks, and in control mice.

4 In the controls there was no significant effect on the enzyme activities in diaphragm up to 5 days, but there were decreases in EDL, and increases in soleus. In the pretreated group all three forms were increased in diaphragm, especially the A12 form. In soleus and EDL there was a prolonged decrease in all forms, although in the soleus the A12 activity remained above normal.

5 Repeated treatment with pyridostigmine caused de layed changes in functional acetylcholinesterase. Furthermore the treatment had altered the sensitivity of the muscles to the drug.

Key Words: acetylcholinesterase • neuromuscular junction • muscle • anticholinesterase • pyridostigmine

Human & Experimental Toxicology, Vol. 16, No. 3, 158-165 (1997)
DOI: 10.1177/096032719701600305


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D S Gill, M C Lintern, J Wetherell, J H Coote, and M E Smith Guinea-pig heart acetylcholinesterase after continuous physostigmine administration Human and Experimental Toxicology, July 1, 2003; 22(7): 373 - 381. [Abstract] [PDF]